AKR1C1 and AKR1C3 are members of the AKR superfamily which has been previously shown to be associated with oncogenic potential and proliferation capacity (55), and selective targeting of AKR1C proteins in GBM could delay the acquisition of resistance to TMZ of astroglioma cells (56). The gene discussed is AKR1C1; the disease is glioblastoma.